Skip to main content
Premium Trial:

Request an Annual Quote

Government Chooses Developer for New NCI Complex

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US General Services Administration has chosen The JBG Companies of Chevy Chase, Md., to build a new $200 million complex in Rockville, Md., that will serve as a new home base for the National Cancer Institute, now housed in two facilities about 7 miles apart.

The 575,000-square-foot complex will be built on a nine-acre portion of Johns Hopkins University's Montgomery County campus, within the Shady Grove Life Sciences Center, the business park that houses much of the life sciences sector in Maryland's Montgomery County. JBG would develop and own the building under a ground lease it has signed with Johns Hopkins.

NCI's new campus — at the southwest corner of the intersection of Medical Center Drive and Key West Avenue — will consist of twin seven-story buildings with a shared entrance, as well as nearly 12,000 square feet of street retail space that will wrap around one of the site's three planned parking structures.

JBG said in a statement it will build NCI's new campus with energy efficient features designed to earn the second-highest "gold" Leadership in Energy and Environmental Design, or LEED, certification.

NCI will house 2,100 employees at the Shady Grove campus when it completes its relocation there in 2013, the agency said on its web site. The employees are now scattered between the agency's headquarters campus in Bethesda, Md., and offices further north in Gaithersburg, Md.

"NCI's new Shady Grove Campus will set a standard that will attract public and private science initiatives focused on solving vital health challenges for decades to come," JBG Principal Rod Lawrence said in a statement.

Filed under

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.